Dow Jones Industrial Average Turns 130 Why the Oldest Stock Index Still Matters
Trump Postpones AI Executive Order Signing Citing Concerns Over Potential Regulatory Blocker
Genpact CEO Highlights AIDriven Reduction in IT Workload and Employment Growth
European Manufacturers Maintain China Production Despite EU DeRisking Rhetoric
China Calls for APEC Cooperation as Commerce Minister Skips Opening Due to Urgent Official Business
Vickers Insider Trading Report Key Buyers and Sellers for May 26 2026
OFS Credit Company Inc OCCI Q1 2026 Earnings Massive EPS Miss Highlights Credit Portfolio Headwinds
CANF Q4 2023 Earnings NarrowerthanExpected Loss Signals Operational Progress
CRH Q1 2026 Earnings NarrowerThanExpected Loss Signals Resilience Amid Market Headwinds
JOE Q1 2026 Earnings EPS of 024 as Stock Edges Lower
CTNM Q1 2026 Earnings Significant EPS Beat Amid Pipeline Progress Stock Slightly Down
REAL Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Stock Reaction
MediaAlpha MAX Edges Higher in Quiet Trading Holds Near Key Support
Blue Bird Corporation BLBD Edges Lower Amid Market Consolidation
Bitcoin Infrastructure Acquisition Corp BIXI Holds Steady at 997 Consolidation in Focus
rYojbaba Co Ltd RYOJ Faces Sharp 15 Drop as Support Levels Are Tested
Invesco Mortgage Capital IVR Edges Lower Amid Broader Mortgage REIT Pressure
US Consumer Prices Rise 38 Annually in April Highest Since May 2023
WSBCO Q1 2026 Earnings Preferred Stock Underwhelms Despite Solid EPS Beat
Buenaventura Mining BVN Edges Lower as Precious Metals Pull Back
CSV Q1 2026 Earnings Slight EPS Beat Amid Mixed Market Reaction
Greenidge Generation Holdings 850 Senior Notes GREEL Q1 2025 Earnings Narrowed Loss Exceeds Expectations as Stock Reacts Cautiously
SailPoint Q1 2026 Earnings EPS Barely Misses Estimates Shares Rally
ADPT Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Sentiment
BETR Q1 2026 Earnings WiderthanExpected Loss as Company Navigates Challenging Market
FFIV Q1 2026 Earnings EPS Surges Past Estimates as Software Growth Drives Profitability
SRPT Q1 2026 Earnings EPS Smashes Estimates by 1847 as Gene Therapy Execution Drives Profit Surprise